S&P 500   5,009.00 (-0.26%)
DOW   37,762.47 (+0.02%)
QQQ   423.84 (-0.47%)
AAPL   167.09 (-0.54%)
MSFT   404.86 (-1.69%)
META   502.20 (+1.62%)
GOOGL   156.29 (+0.53%)
AMZN   179.43 (-1.02%)
TSLA   150.55 (-3.15%)
NVDA   847.87 (+0.89%)
AMD   154.93 (+0.59%)
NIO   4.02 (+2.81%)
BABA   68.92 (+0.15%)
T   16.28 (+0.99%)
F   12.02 (-0.17%)
MU   112.43 (-3.35%)
GE   153.80 (-1.20%)
CGC   7.92 (+22.03%)
DIS   112.82 (-0.11%)
AMC   2.96 (-0.67%)
PFE   25.38 (-0.16%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)
S&P 500   5,009.00 (-0.26%)
DOW   37,762.47 (+0.02%)
QQQ   423.84 (-0.47%)
AAPL   167.09 (-0.54%)
MSFT   404.86 (-1.69%)
META   502.20 (+1.62%)
GOOGL   156.29 (+0.53%)
AMZN   179.43 (-1.02%)
TSLA   150.55 (-3.15%)
NVDA   847.87 (+0.89%)
AMD   154.93 (+0.59%)
NIO   4.02 (+2.81%)
BABA   68.92 (+0.15%)
T   16.28 (+0.99%)
F   12.02 (-0.17%)
MU   112.43 (-3.35%)
GE   153.80 (-1.20%)
CGC   7.92 (+22.03%)
DIS   112.82 (-0.11%)
AMC   2.96 (-0.67%)
PFE   25.38 (-0.16%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)
S&P 500   5,009.00 (-0.26%)
DOW   37,762.47 (+0.02%)
QQQ   423.84 (-0.47%)
AAPL   167.09 (-0.54%)
MSFT   404.86 (-1.69%)
META   502.20 (+1.62%)
GOOGL   156.29 (+0.53%)
AMZN   179.43 (-1.02%)
TSLA   150.55 (-3.15%)
NVDA   847.87 (+0.89%)
AMD   154.93 (+0.59%)
NIO   4.02 (+2.81%)
BABA   68.92 (+0.15%)
T   16.28 (+0.99%)
F   12.02 (-0.17%)
MU   112.43 (-3.35%)
GE   153.80 (-1.20%)
CGC   7.92 (+22.03%)
DIS   112.82 (-0.11%)
AMC   2.96 (-0.67%)
PFE   25.38 (-0.16%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)
S&P 500   5,009.00 (-0.26%)
DOW   37,762.47 (+0.02%)
QQQ   423.84 (-0.47%)
AAPL   167.09 (-0.54%)
MSFT   404.86 (-1.69%)
META   502.20 (+1.62%)
GOOGL   156.29 (+0.53%)
AMZN   179.43 (-1.02%)
TSLA   150.55 (-3.15%)
NVDA   847.87 (+0.89%)
AMD   154.93 (+0.59%)
NIO   4.02 (+2.81%)
BABA   68.92 (+0.15%)
T   16.28 (+0.99%)
F   12.02 (-0.17%)
MU   112.43 (-3.35%)
GE   153.80 (-1.20%)
CGC   7.92 (+22.03%)
DIS   112.82 (-0.11%)
AMC   2.96 (-0.67%)
PFE   25.38 (-0.16%)
PYPL   62.22 (-1.64%)
XOM   118.40 (-0.19%)
LON:CTEC

ConvaTec Group (CTEC) Share Price, News & Analysis

GBX 283.60
+2.60 (+0.93%)
(As of 04:35 PM ET)
Today's Range
280.40
283.60
50-Day Range
234.60
293.58
52-Week Range
195.10
295.20
Volume
4.25 million shs
Average Volume
5.36 million shs
Market Capitalization
£5.81 billion
P/E Ratio
5,672.00
Dividend Yield
1.76%
Price Target
GBX 307.17

ConvaTec Group MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
8.3% Upside
GBX 307.17 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.35 out of 5 stars

CTEC stock logo

About ConvaTec Group Stock (LON:CTEC)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

CTEC Stock Price History

CTEC Stock News Headlines

ConvaTec Group (LON:CTEC) Sets New 12-Month Low at $2.87
Convatec Group PLC: Director/ PDMR Shareholding -2-
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
Convatec Group PLC: Director/ PDMR Shareholding
ConvaTec Group PLC FY EPS 6.3c
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
ConvaTec Group PLC (CTEC)
Convatec Group Plc (CTEC.L)
Convatec Group PLC: TR-1 Notification of Major Holdings
Convatec Group PLC: HOL-Holding(s) in Company
CTEC.L - ConvaTec Group PLC
Convatec Group PLC: Total Voting Rights
Convatec Group PLC: Result of AGM
2 cheap shares I’d buy as the FTSE 100 slides
Convatec Group PLC: Annual Report and Accounts 2022 and Notice of AGM
See More Headlines
Receive CTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2020
Today
4/18/2024
Ex-Dividend for 5/23 Dividend
4/25/2024
Dividend Payable
5/23/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
10,136
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 307.17
High Stock Price Target
GBX 323
Low Stock Price Target
GBX 300
Potential Upside/Downside
+8.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
£130.30 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.14 billion
Cash Flow
GBX 16.58 per share
Book Value
GBX 83 per share

Miscellaneous

Outstanding Shares
2,050,000,000
Free Float
N/A
Market Cap
£5.78 billion
Optionable
Not Optionable
Beta
0.55
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Karim Bitar (Age 59)
    CEO & Director
    Comp: $2.97M
  • Mr. Jonathan Peter Mason (Age 60)
    Group CFO & Director
    Comp: $1.59M
  • Mr. John Haller
    Executive VP and Chief Quality & Operations Officer
  • Dr. Divakar Ramakrishnan Ph.D.
    Executive VP, Chief Technology Officer and Head of Research & Development
  • Ms. Kate Postans
    Vice President of Investor Relations & Corporate Communications
  • Ms. Evelyn Douglas J.D.
    Executive VP, Chief of Corporate Strategy & Business Development and General Counsel
  • Ms. Moyra Withycombe
    Interim Chief People Officer
  • Ms. Kjersti Grimsrud Biotechnology (Age 63)
    M.Sc., President & COO of Infusion Care
  • Mr. David Shepherd
    President & COO of Global Advanced Wound Care
  • Mr. Seth R. Segel (Age 55)
    President and COO of Continence Care & Home Services Group

CTEC Stock Analysis - Frequently Asked Questions

Should I buy or sell ConvaTec Group stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CTEC shares.
View CTEC analyst ratings
or view top-rated stocks.

What is ConvaTec Group's stock price target for 2024?

6 brokerages have issued 12 month price targets for ConvaTec Group's shares. Their CTEC share price targets range from GBX 300 to GBX 323. On average, they expect the company's stock price to reach GBX 307.17 in the next twelve months. This suggests a possible upside of 8.3% from the stock's current price.
View analysts price targets for CTEC
or view top-rated stocks among Wall Street analysts.

How have CTEC shares performed in 2024?

ConvaTec Group's stock was trading at GBX 244.20 at the beginning of the year. Since then, CTEC shares have increased by 16.1% and is now trading at GBX 283.60.
View the best growth stocks for 2024 here
.

How were ConvaTec Group's earnings last quarter?

ConvaTec Group PLC (LON:CTEC) issued its quarterly earnings results on Friday, February, 28th. The company reported $12.00 EPS for the quarter, missing the consensus estimate of $12.70 by $0.70. ConvaTec Group had a trailing twelve-month return on equity of 7.89% and a net margin of 6.08%.

How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group?

ConvaTec Group announced a dividend on Wednesday, March 6th. Investors of record on Thursday, April 25th will be given a dividend of GBX 0.04 per share on Thursday, May 23rd. This represents a yield of 1.39%. The ex-dividend date of this dividend is Thursday, April 25th. This is a boost from the stock's previous dividend of GBX 0.02. The official announcement can be accessed at this link.
Read our dividend analysis for CTEC
.

Is ConvaTec Group a good dividend stock?

ConvaTec Group (LON:CTEC) pays an annual dividend of GBX 5 per share and currently has a dividend yield of 1.69%. The dividend payout ratio is 10,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for CTEC.

What other stocks do shareholders of ConvaTec Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ConvaTec Group investors own include EnQuest (ENQ), Centamin (CEY), Oxford Biomedica (OXB), Bristol-Myers Squibb (BMY), Andalas Energy and Power (ADL), AFR.L (AFR), CBTX (CBTX), Genel Energy (GENL), Premier Oil (PMO) and Playtech (PTEC).

How do I buy shares of ConvaTec Group?

Shares of CTEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:CTEC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners